July 24, 2014 2:40 PM ET

Pharmaceuticals

Company Overview of Exponential Biotherapies, Inc.

Executive Profile

Michael Brownstein Prof. M.D., Ph.D.

Chairman of Scientific Advisory Board and Chief Scientific Officer, Exponential Biotherapies, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 9 different industries.

See Board Relationships
----

Background

Dr. Michael J. Brownstein, M.D., Ph.D. serves as the Chief Scientific Officer at Exponential Biotherapies Inc. Dr. Brownstein serves as Vice President of Drug Development of Azevan Pharmaceuticals, Inc. He serves as a Consultant of Avineuro Pharmaceuticals, Inc. He serves as the Chief of the Laboratory of Genetics at the National Institute of Mental Health/National Human Genome Research Institute at the National Institutes of Health (NIH). He served as the Chief of the ...

Corporate Headquarters

7921 Jones Branch Drive
McLean, Virginia 22102

United States

Phone: 703-883-3701
Fax: 703-883-3704

Board Members Memberships

Director and Chairman of Scientific Advisory Board

Education

PhD
The University of Chicago
MD
The University of Chicago
Bachelor's Degree
Columbia University
MD
Lund University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Exponential Biotherapies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.